Sfoglia per Autore  Nardella, Caterina

Opzioni
Mostrati risultati da 1 a 20 di 27
Titolo Anno di pubblicazione Autori Unitn File
Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein 1-gen-2001 Nardella C. +
Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity 1-gen-2004 Nardella C. +
Mechanism of Activation of Human Heparanase Investigated by Protein Engineering 1-gen-2004 Nardella C. +
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer 1-gen-2008 Nardella C. +
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events 1-gen-2008 Nardella C. +
Differential requirement of mTOR in postmitotic tissues and tumorigenesis 1-gen-2009 Nardella C.Chen, Zheng +
ETS rearrangements and prostate cancer initiation 1-gen-2009 Nardella C. +
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate 1-gen-2009 Nardella C. +
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence 1-gen-2010 Nardella C. +
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis 1-gen-2010 Nardella C. +
Faithfull modeling of PTEN loss driven diseases in the mouse 1-gen-2010 Nardella, Caterina +
Subtle variations in Pten dose determine cancer susceptibility 1-gen-2010 Nardella C. +
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis 1-gen-2011 Nardella, CaterinaLunardi, Andrea +
The APL paradigm and the "co-clinical trial" project 1-gen-2011 Nardella, CaterinaLunardi, Andrea +
Pro-senescence therapy for cancer treatment 1-gen-2011 Nardella C. +
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence 1-gen-2012 Nardella C. +
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer 1-gen-2012 Nardella C. +
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer 1-gen-2013 Lunardi, AndreaNardella, Caterina +
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion 1-gen-2013 Lunardi, AndreaNardella, Caterina +
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells 1-gen-2013 Nardella, Caterina +
Mostrati risultati da 1 a 20 di 27
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile